The marker genes OLR1 and SLC7A7, which were significantly upregulated in LEMS, were validated in clinical samples, suggesting their potential as biomarkers for pancreatic cancer liver metastases. The gene discussed is SLC7A7; the disease is pancreatic neoplasm.